The impact of non-tumor-derived circulating nucleic acids implicates the prognosis of non-small cell lung cancer

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 1, 2013, Pages 67-76

  Vinayanuwattikun, Chanida ^a   Winayanuwattikun, Pakorn ^a   Chantranuwat, Poonchavist ^a   Mutirangura, Apiwat ^a   Sriuranpong, Virote ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Circulating nucleic acid; Non epithelial specific methylation marker; Non small cell lung cancer; SHP 1 promoter 2

Indexed keywords

DNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PROTEIN TYROSINE PHOSPHATASE SHP 1;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID ANALYSIS; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN TYROSINE PHOSPHATASE SHP 1 GENE; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NUCLEIC ACIDS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; SMOKING; SURVIVAL ANALYSIS;

EID: 84872334671     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1300-5     Document Type: Article

References (35)

1. Andriani F, Conte D, Mastrangelo T, Leon M, Ratcliffe C, Roz L, Pelosi G, Goldstraw P, Sozzi G, Pastorino U (2004) Detecting lung cancer in plasma with the use of multiple genetic markers. Int J Cancer 108(1):91-96
2. Anker P, Mulcahy H, Chen XQ, Stroun M (1999) Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev 18(1):65-73
3. Balkwill F, Charles KA, Mantovani A (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7(3):211-217. doi: 10.1016/j.ccr.2005.02.013
4. Bastian PJ, Palapattu GS, Yegnasubramanian S, Lin X, Rogers CG, Mangold LA, Trock B, Eisenberger M, Partin AW, Nelson WG (2007) Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy. Clin Cancer Res 13(18 Pt 1):5361-5367. doi: 10.1158/1078-0432.CCR-06-2781
5. Beck J, Urnovitz HB, Riggert J, Clerici M, Schutz E (2009) Profile of the circulating DNA in apparently healthy individuals. Clin Chem 55(4):730-738. doi: 10.1373/clinchem.2008.113597
6. Boni L, Cassinotti E, Canziani M, Dionigi G, Rovera F, Dionigi R (2007) Free circulating DNA as possible tumour marker in colorectal cancer. Surg Oncol 16(Suppl 1):S29-S31. doi: 10.1016/j.suronc.2007.10.004
7. Butt AN, Swaminathan R (2008) Overview of circulating nucleic acids in plasma/serum. Ann N Y Acad Sci 1137:236-242
8. Choi JJ, Reich CF 3rd, Pisetsky DS (2005) The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells. Immunology 115(1):55-62. doi: 10.1111/j.1365-2567.2005.02130.x
9. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG (1999) Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 59(1):67-70
10. Frattini M, Gallino G, Signoroni S, Balestra D, Battaglia L, Sozzi G, Leo E, Pilotti S, Pierotti MA (2006) Quantitative analysis of plasma DNA in colorectal cancer patients: a novel prognostic tool. Ann N Y Acad Sci 1075:185-190. doi: 10.1196/annals.1368.025
11. Garcia-Olmo DC, Samos J, Picazo MG, Asensio AI, Toboso I, Garcia-Olmo D (2008) Release of cell-free DNA into the bloodstream leads to high levels of non-tumor plasma DNA during tumor progression in rats. Cancer Lett 272(1):133-140. doi: 10.1016/j.canlet.2008.07.003
12. Garcia-Olmo DC, Dominguez C, Garcia-Arranz M, Anker P, Stroun M, Garcia-Verdugo JM, Garcia-Olmo D (2010) Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells. Cancer Res 70(2):560-567. doi: 10.1158/0008-5472. CAN-09-3513
13. Gautschi O, Bigosch C, Huegli B, Jermann M, Marx A, Chasse E, Ratschiller D, Weder W, Joerger M, Betticher DC, Stahel RA, Ziegler A (2004) Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol 22(20):4157-4164
14. Goebel G, Zitt M, Muller HM (2005) Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias. Dis Markers 21(3):105-120
15. Grunau C, Clark SJ, Rosenthal A (2001) Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res 29(13):E65
16. Hsu HS, Chen TP, Hung CH, Wen CK, Lin RK, Lee HC, Wang YC (2007) Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma. Cancer 110(9):2019-2026
17. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R (2001) DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61(4):1659-1665
18. Jiang N, Reich CF 3rd, Pisetsky DS (2003) Role of macrophages in the generation of circulating blood nucleosomes from dead and dying cells. Blood 102(6):2243-2250. doi: 10.1182/blood-2002-10-3312
19. Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, Kim Y, Luo JL, Karin M (2009) Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457(7225):102-106. doi: 10.1038/nature07623
20. Kondratiev S, Sabo E, Yakirevich E, Lavie O, Resnick MB (2004) Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma. Clin Cancer Res 10(13):4450-4456. doi: 10.1158/1078-0432.CCR-0732-3
21. Kopreski MS, Benko FA, Borys DJ, Khan A, McGarrity TJ, Gocke CD (2000) Somatic mutation screening: identification of individuals harboring K-ras mutations with the use of plasma DNA. J Natl Cancer Inst 92(11):918-923
22. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37(3):646-650
23. Lui YY, Chik KW, Chiu RW, Ho CY, Lam CW, Lo YM (2002) Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 48(3):421-427
24. Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H (1998) CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58(16):3491-3494
25. Piras F, Colombari R, Minerba L, Murtas D, Floris C, Maxia C, Corbu A, Perra MT, Sirigu P (2005) The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase. Cancer 104(6):1246-1254. doi: 10.1002/cncr.21283
26. Pisetsky DS, Ullal AJ (2010) The blood nucleome in the pathogenesis of SLE. Autoimmun Rev 10(1):35-37. doi: 10.1016/j.autrev.2010.07.007
27. Ponomaryova AA, Rykova EY, Cherdyntseva NV, Skvortsova TE, Dobrodeev AY, Zav'yalov AA, Tuzikov SA, Vlassov VV, Laktionov PP (2011) RARbeta2 gene methylation level in the circulating DNA from blood of patients with lung cancer. Eur J Cancer Prev 20(6):453-455. doi: 10.1097/CEJ.0b013e3283498eb4
28. Ruchusatsawat K, Wongpiyabovorn J, Shuangshoti S, Hirankarn N, Mutirangura A (2006) SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis. J Mol Med 84(2):175-182 (Berlin, Germany)
29. Schumacher K, Haensch W, Roefzaad C, Schlag PM (2001) Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. Cancer Res 61(10):3932-3936
30. Silva JM, Silva J, Sanchez A, Garcia JM, Dominguez G, Provencio M, Sanfrutos L, Jareno E, Colas A, Espana P, Bonilla F (2002) Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival. Clin Cancer Res 8(12):3761-3766
31. Sozzi G, Conte D, Leon M, Ciricione R, Roz L, Ratcliffe C, Roz E, Cirenei N, Bellomi M, Pelosi G, Pierotti MA, Pastorino U (2003) Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 21(21):3902-3908
32. Vinayanuwattikun C, Sriuranpong V, Tanasanvimon S, Chantranuwat P, Mutirangura A (2011) Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer. J Thorac Oncol 6(11):1818-1825. doi: 10.1097/JTO.0b013e318226b46f
33. Wu C, Sun M, Liu L, Zhou GW (2003) The function of the protein tyrosine phosphatase SHP-1 in cancer. Gene 306:1-12. doi: S0378111903004001
34. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348(3):203-213. doi: 10.1056/NEJMoa020177
35. Zitt M, Muller HM, Rochel M, Schwendinger V, Goebel G, Devries A, Margreiter R, Oberwalder M, Zeillinger R, Ofner D (2008) Circulating cell-free DNA in plasma of locally advanced rectal cancer patients undergoing preoperative chemoradiation: a potential diagnostic tool for therapy monitoring. Dis Markers 25(3):159-165